GLUE Operating Expenses

Monte Rosa Therapeutics Inc · Operating Expenses

GLUE logo

GLUE Operating Expenses

Latest reported$208.55M
GLUE TTM Operating Expenses ($28.01M → $208.55M)
High-resolution chart · PNG

GLUE operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Monte Rosa Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
208,552,000
189,202,000
177,880,000
173,027,000
163,027,000
159,556,000
152,777,000
139,997,000
141,222,000
143,166,000
143,311,000
140,937,000
132,331,000
122,341,000
112,384,000
103,282,000
94,788,000
85,680,000
72,882,000
61,431,000
47,949,000
35,222,000
28,011,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.